<SEC-DOCUMENT>0001140361-24-037341.txt : 20240814
<SEC-HEADER>0001140361-24-037341.hdr.sgml : 20240814
<ACCEPTANCE-DATETIME>20240814163549
ACCESSION NUMBER:		0001140361-24-037341
CONFORMED SUBMISSION TYPE:	DEFA14A
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20240814
DATE AS OF CHANGE:		20240814

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MOTORCAR PARTS OF AMERICA INC
		CENTRAL INDEX KEY:			0000918251
		STANDARD INDUSTRIAL CLASSIFICATION:	MOTOR VEHICLE PARTS & ACCESSORIES [3714]
		ORGANIZATION NAME:           	04 Manufacturing
		IRS NUMBER:				112153962
		STATE OF INCORPORATION:			NY
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		DEFA14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33861
		FILM NUMBER:		241208777

	BUSINESS ADDRESS:	
		STREET 1:		2929 CALIFORNIA STREET
		CITY:			TORRANCE
		STATE:			CA
		ZIP:			90503
		BUSINESS PHONE:		3109724015

	MAIL ADDRESS:	
		STREET 1:		2929 CALIFORNIA STREET
		CITY:			TORRANCE
		STATE:			CA
		ZIP:			90503

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MOTORCAR PARTS AMERICA INC
		DATE OF NAME CHANGE:	20100614

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MOTORCAR PARTS  AMERICA INC
		DATE OF NAME CHANGE:	20040112

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MOTORCAR PARTS & ACCESSORIES INC
		DATE OF NAME CHANGE:	19940128
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEFA14A
<SEQUENCE>1
<FILENAME>ef20034155_formdefa14a.htm
<DESCRIPTION>DEFA14A
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions. Inc.
         Document created using Broadridge PROfile 24.6.2.5244
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div> <br>
    </div>
    <div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-size: 14pt; font-weight: bold;">UNITED STATES</div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-size: 12pt; font-weight: bold;">Washington, D.C. 20549</div>
      <div><br>
      </div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-size: 18pt; font-weight: bold;">SCHEDULE 14A</div>
      <div style="text-align: center; color: #000000; font-weight: bold;">Proxy Statement Pursuant to Section 14(a)</div>
      <div style="text-align: center; color: #000000; font-weight: bold;">of the Securities Exchange Act of 1934</div>
      <div style="text-align: center; color: #000000; font-weight: bold;">(Amendment No. 1)</div>
      <div><br>
      </div>
      <div style="color: #000000;">Filed by the Registrant &#9746;</div>
      <div style="color: #000000;">Filed by a Party other than the Registrant &#8201;&#9744;</div>
      <div style="color: #000000;">Check the appropriate box:</div>
      <div><br>
      </div>
      <div style="color: #000000;">&#8201;&#9744; Preliminary Proxy Statement</div>
      <div style="color: #000000;">&#8201;&#9744; <font style="font-weight: bold;">Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</font></div>
      <div style="color: #000000;">&#8201;&#9744; Definitive Proxy Statement</div>
      <div style="color: #000000;">&#160;&#9746; Definitive Additional Materials</div>
      <div style="color: #000000;">&#8201;&#9744; Soliciting Material Pursuant to &#167;240.14a-12</div>
      <div><font style="color: #000000;"> </font><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z88234c263a194432b10db6a6c721a9a3">

          <tr>
            <td style="width: 100%; vertical-align: top; font-size: 24pt; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">MOTORCAR PARTS OF AMERICA, INC.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 100%; vertical-align: top;">
              <div style="text-align: center; color: #000000; font-weight: bold;">(Name of Registrant as Specified In Its Charter)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 100%; vertical-align: top;">
              <div style="text-align: center; color: #000000; font-weight: bold;">(Name of Person(s) Filing Proxy Statement, if other than the Registrant)</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="color: #000000;">Payment of Filing Fee (Check the appropriate box):</div>
      <div><br>
      </div>
      <div style="color: #000000;">&#160;&#9746; No fee required.</div>
      <div style="color: #000000;">&#8201;&#9744; Fee paid previously with preliminary materials.</div>
      <div style="color: #000000;">&#8201;&#9744; Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.</div>
      <div>&#160;</div>
      <div>
        <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"> </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center;"><img src="logo1.jpg"></div>
      <div><br>
      </div>
      <div style="text-align: center; color: #000000; font-weight: bold;">MOTORCAR PARTS OF AMERICA, INC.</div>
      <div style="text-align: center; color: #000000; font-weight: bold;">SUPPLEMENT TO PROXY STATEMENT DATED JULY 26, 2024 FOR ANNUAL MEETING OF</div>
      <div style="text-align: center; color: #000000; font-weight: bold;">SHAREHOLDERS TO BE HELD ON<a name="tNOTICE"></a> SEPTEMBER 5, 2024</div>
      <div><br>
      </div>
      <div style="color: #000000;">Proxy Statement Supplement</div>
      <div><br>
      </div>
      <div style="color: #000000;">To Our Shareholders:</div>
      <div><br>
      </div>
      <div style="text-align: justify; color: #000000;">The proxy statement supplement dated August 14, 2024 (the &#8220;Supplement&#8221;) supplements the proxy statement (the &#8220;Proxy Statement&#8221;) filed by Motorcar Parts of America, Inc., a New York corporation (the
        &#8220;Company&#8221; or &#8220;we&#8221;), with the Securities and Exchange Commission on July 26, 2024 for the 2024 annual meeting of shareholders (the &#8220;Annual Meeting&#8221;) to be held on September 5, 2024 at 10:00 a.m. (PT) at the offices of the Company at 2929 California
        Street, Torrance, California 90503. The Proxy Statement contains important additional information. This Supplement should only be read in conjunction with the Proxy Statement, and except as updated by this Supplement, all information set forth in
        the Proxy Statement remains unchanged and should be considered in casting your vote by proxy or at the Annual meeting.</div>
      <div><br>
      </div>
      <div style="text-align: justify; color: #000000;">The primary purpose of this Supplement is to provide subsequent information relating to Proposal No. 4 in the Proxy Statement, in which we ask our shareholders to approve the First Amendment to the
        Motorcar Parts of America, Inc. 2022 Incentive Award Plan (&#8220;First Amendment&#8221;). As described in greater detail below, the Company is supplementing the information included in Proposal 4 of the Proxy Statement to reduce the proposed requested share
        reserve increase under the Motorcar Parts of America, Inc. 2022 Incentive Award Plan from 1,871,000 shares to 1,731,000 shares.</div>
      <div><br>
      </div>
      <div style="text-align: justify; color: #000000;">Except for the changes herein, this Supplement does not modify any other information set forth in the Proxy Statement. This Supplement is first being distributed to shareholders on or about August 14,
        2024.</div>
      <div><br>
      </div>
      <div style="text-align: justify; color: #000000; font-weight: bold;">Voting Matters</div>
      <div><br>
      </div>
      <div style="text-align: justify; color: #000000;">Please note that any proxy card that you requested or that we elected to deliver has not changed and may still be used to vote your shares in connection with the Annual Meeting. If you have already
        submitted your vote, you do not need to take any further action. Information on how to vote your shares and how to change your vote or revoke your proxy is contained in the Proxy Statement. The Company urges shareholders to vote their shares prior
        to the Annual Meeting by using one of the methods described in the Proxy Statement</div>
      <div><br>
      </div>
      <div><img src="sig1.jpg"></div>
      <div><br>
      </div>
      <div style="color: #000000;">Juliet Stone, Secretary</div>
      <div style="color: #000000;">Torrance, California</div>
      <div style="color: #000000;">August 14, 2024</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div><br>
      </div>
      <div style="text-align: center; color: #000000; font-weight: bold;"><u>Supplement to Proposal No. 4 of Proxy Statement</u></div>
      <div><br>
      </div>
      <div style="text-align: justify; color: #000000; font-weight: bold;">Additional Information regarding Proposal No. 4</div>
      <div><br>
      </div>
      <div style="text-align: justify; color: #000000;">The following information supplements the Company&#8217;s request under Proposal No. 4 to approve the First Amendment.</div>
      <div><br>
      </div>
      <div style="text-align: justify; color: #000000;">Subject to shareholder approval, in July 2024, our Board of Directors approved the First Amendment to, among other things, provide for a share reserve increase of up to 1,871,000 shares over the
        existing share reserve under the existing Plan. The Proxy Statement discusses the proposed First Amendment, which provided for a share reserve increase of 1,871,000 shares, and provides a copy of the original First Amendment.</div>
      <div><br>
      </div>
      <div style="text-align: justify; color: #000000;">After making the Proxy Statement available to shareholders, the proposal to approve the First Amendment received an unfavorable recommendation from a proxy advisory firm. After consideration of the
        unfavorable recommendation, the Company determined to update the First Amendment to (1) reduce the proposed share reserve increase from 1,871,000 shares to 1,731,000 shares, and (2) accordingly, reduce the proposed increase to the aggregate number
        of shares which may be granted as incentive stock options from 1,871,000 shares to 1,731,000 shares, but with no other changes to the First Amendment as described in the Proxy Statement. The proposed 1,731,000 share increase will reduce the
        potential dilutive impact of the First Amendment on shareholders as compared to the originally proposed 1,871,000 share increase.</div>
      <div><br>
      </div>
      <div style="text-align: justify; color: #000000;">The foregoing is a summary description of the update to the First Amendment and is qualified in its entirety by reference to the updated First Amendment, a copy of which is attached hereto as
        Supplement Appendix A, which amends and replaces the First Amendment as filed as Appendix B to the Proxy Statement. The following restates certain information originally disclosed in Proposal No. 4.</div>
      <div><br>
      </div>
      <div>
        <div style="color: #000000; font-weight: bold;">Background of Determination of Shares Under the Plan Amendment</div>
        <div><br>
        </div>
      </div>
      <div>
        <div style="text-align: justify; color: #000000;">As mentioned above, in its determination to approve the Plan Amendment, the Board was primarily motivated by a desire to ensure the Company has an available pool of shares from which to grant
          long-term equity-based incentive awards, which the Board believes is an incentive and retention mechanism for our employees, consultants and non-employee directors. The Board considered key factors in making its determination including our
          historical grant rates, the shares remaining available for issuance under the Plan, and the potential dilution associated with the Plan. This review included a consideration of the following key metrics, factors and philosophies:</div>
      </div>
      <div>
        <div><br>
        </div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z696c598aa6f84b449ed28c31b0b43fc0">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: #000000;">In Fiscal Year 2024, we granted equity awards covering 818,340 shares of our common stock, of which 585,583 were performance-based awards assuming performance &#8220;at target&#8221;. On average, over the fiscal 2022&#8212;2024
                period, we granted 518,373 shares annually. The amounts include PSUs based on the achievement of &#8220;target&#8221; performance goals.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z95467b702b9943aa99e4e0b14a19003f">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: #000000;">Our three-year average annual share pool usage over the most recently completed three-fiscal year period (or &#8220;burn rate&#8221;) was approximately 2.67%, as shown in the following table.</div>
            </td>
          </tr>

      </table>
      <div>
        <table cellspacing="0" cellpadding="0" class="cfttable" id="z4fc127302fdc4a0ba05c8b1b82daba01" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">

            <tr>
              <td valign="bottom" style="vertical-align: bottom;">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-weight: bold;">Burn Rate Information</div>
              </td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom;">&#160;</td>
              <td valign="bottom" colspan="2" style="vertical-align: bottom;">
                <div style="text-align: center; color: #000000; font-weight: bold;">FY 2022</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom;">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom;">&#160;</td>
              <td valign="bottom" colspan="2" style="vertical-align: bottom;">
                <div style="text-align: center; color: #000000; font-weight: bold;">FY 2023</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom;">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom;">&#160;</td>
              <td valign="bottom" colspan="2" style="vertical-align: bottom;">
                <div style="text-align: center; color: #000000; font-weight: bold;">FY 2024</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom;">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom;">&#160;</td>
              <td valign="bottom" colspan="2" style="vertical-align: bottom;">
                <div style="text-align: center; color: #000000; font-weight: bold;">Three-Year</div>
                <div style="text-align: center; color: #000000; font-weight: bold;">Average</div>
                <div style="text-align: center; color: #000000; font-weight: bold;">(FY 2022 &#8211; FY</div>
                <div style="text-align: center; color: #000000; font-weight: bold;">2024)</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom;">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 52%; background-color: #CCEEFF;">
                <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Time-vesting stock options granted</div>
              </td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                <div style="color: #000000;">&#8212;</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                <div style="color: #000000;">&#8212;</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                <div style="color: #000000;">132,133</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                <div style="color: #000000;">44,044</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 52%;">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Performance-based stock options granted (at &#8220;target&#8221;)</div>
              </td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                <div style="color: #000000;">&#8212;</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                <div style="color: #000000;">&#8212;</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                <div style="color: #000000;">&#8212;</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                <div style="color: #000000;">&#8212;</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 52%; background-color: #CCEEFF;">
                <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Time-vesting RSUs and restricted stock granted</div>
              </td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                <div style="color: #000000;">163,703</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                <div style="color: #000000;">229,121</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                <div style="color: #000000;">100,624</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                <div style="color: #000000;">164,483</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 52%;">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Performance-based restricted stock granted (at &#8220;target&#8221;)</div>
              </td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                <div style="color: #000000;">66,667</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                <div style="color: #000000;">66,667</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                <div style="color: #000000;">&#8212;</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                <div style="color: #000000;">44,445</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 52%; background-color: #CCEEFF;">
                <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">PSUs granted (at &#8220;target&#8221;)</div>
              </td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                <div style="color: #000000;">84,593</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                <div style="color: #000000;">126,028</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                <div style="color: #000000;">585,583</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                <div style="color: #000000;">265,401</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 52%;">
                <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Performance-based stock options earned/vested</div>
              </td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                <div style="color: #000000;">44,199</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                <div style="color: #000000;">&#8212;</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                <div style="color: #000000;">&#8212;</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                <div style="color: #000000;">14,733</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 52%; background-color: #CCEEFF;">
                <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Performance-based restricted stock earned/vested</div>
              </td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                <div style="color: #000000;">99,082</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                <div style="color: #000000;">77,689</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                <div style="color: #000000;">27,508</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                <div style="color: #000000;">68,093</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 52%;">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: #000000;">PSUs earned/vested</div>
              </td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                <div style="color: #000000;">&#8212;</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                <div style="color: #000000;">&#8212;</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                <div style="color: #000000;">&#8212;</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                <div style="color: #000000;">&#8212;</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 52%; background-color: #CCEEFF;">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: #000000;">Total awards granted<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div>
              </td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                <div style="color: #000000;">306,984</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                <div style="color: #000000;">306,810</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                <div style="color: #000000;">260,265</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                <div style="color: #000000;">291,353</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 52%;">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: #000000;">Weighted average common shares outstanding (Basic)</div>
              </td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                <div style="color: #000000;">19,119,727</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                <div style="color: #000000;">19,340,246</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                <div style="color: #000000;">19,601,204</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                <div style="color: #000000;">19,353,726</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 52%; background-color: #CCEEFF;">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: #000000;">Gross burn rate<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup></div>
              </td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                <div style="color: #000000;">1.65</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
                <div style="color: #000000;">%</div>
              </td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                <div style="color: #000000;">2.18</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
                <div style="color: #000000;">%</div>
              </td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                <div style="color: #000000;">4.17</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
                <div style="color: #000000;">%</div>
              </td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                <div style="color: #000000;">2.67</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
                <div style="color: #000000;">%</div>
              </td>
            </tr>

        </table>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8156866de0d64173ae1c2700a467cf02">

          <tr>
            <td style="width: 18pt; vertical-align: top; color: #000000;">(1)</td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: #000000;">Includes (A) time-based stock options granted and time-based RSUs and restricted stock granted and (B) performance-based stock options, performance-based restricted stock, and PSUs vested or earned in the
                applicable year based on actual achievement of performance goals. The number of performance-based stock options that were forfeited during FY 2022, FY 2023, and FY 2024 was 0, 44,201, and 44,199, respectively. The number of
                performance-based restricted shares that were forfeited during FY 2022, FY2023, and FY2024 was 0, 0, 39,159, respectively. The number of PSUs that were forfeited during FY 2022, FY 2023, and FY 2024 was 0, 17,925, and 4,356, respectively.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc8965193950d4662bb38ecb342924e4d">

          <tr>
            <td style="width: 18pt; vertical-align: top; color: #000000;">(2)</td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: #000000;">Gross burn rate is calculated as (A) the total number of stock-settled equity awards granted during the applicable year (with performance awards counted at &#8220;target&#8221; levels), divided (B) by the weighted average
                common shares outstanding for the applicable year.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zce5df8f6daaf4c5fa8fc9ea0277350a0">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: #000000;">An additional metric that we use to measure the cumulative dilutive impact of our equity-based awards program is fully diluted overhang, which is the sum of (1) the number of shares subject to equity awards
                outstanding (assuming performance at the &#8220;target&#8221; performance level), but not exercised or settled and (2) the number of shares available to be granted under our equity compensation plans, divided by the sum of (A) the total common shares
                outstanding, (B) the number of shares subject to equity awards outstanding but not exercised or settled, and (C) the number of shares available to be granted under our equity compensation plans. Our approximate fully-diluted overhang as of
                June 1, 2024, was 11.5%. If the Plan Amendment had been approved as of such date, our approximate potential overhang, on a fully-diluted basis, would increase by 6.4% to 17.9% and then would decline over time.</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div>
        <div style="text-align: justify; color: #000000;">If approved by our shareholders, the Plan Amendment would increase the aggregate number of shares available for grant by 1,731,000 shares of common stock.</div>
        <div><br>
        </div>
        <div style="text-align: justify; color: #000000;">If we exhaust the share reserve under the Plan without approval of the Plan Amendment, we would lose an important element of our compensation program that is essential to attract, motivate and
          retain highly qualified talent, and that aligns the interests of our employees with our shareholders.</div>
        <div><br>
        </div>
        <div style="text-align: justify; color: #000000;">In light of the factors described above, the Board believes that the size of the share reserve proposed by the Plan Amendment is reasonable and appropriate at this time.</div>
        <div><br>
        </div>
        <div style="text-align: justify; color: #000000;">To the extent we grant any awards between June 1, 2024 and the date of this Annual Meeting, the available share reserve under the Amended Plan will be reduced from 431,875 shares (i.e., the
          remaining available reserve as of June 1, 2024 (431,875 shares, assuming the payout of outstanding PSUs, performance-based stock options and performance-based restricted stock at &#8220;target&#8221; performance goals) plus 1,731,000 shares) by the number of
          shares that we grant during such period.</div>
      </div>
      <div>
        <div><br>
        </div>
        <div style="color: #000000; font-weight: bold;">Shareholder Approval</div>
        <div><br>
        </div>
      </div>
      <div>
        <div style="text-align: justify; color: #000000;">As mentioned above, if this Plan Amendment is approved, then as of the Amendment Effective Date, an aggregate of (i) 2,655,200 shares and (ii) any shares which are subject to awards outstanding
          under the 2010 Plan and the 2014 Non-Employee Director Incentive Award Plan (the &#8220;Director Plan&#8221;) which become available for issuance under the Amended Plan following the effective date of the existing Plan will be reserved for issuance pursuant
          to the Amended Plan, all of which may be granted as ISOs pursuant to Section 422 of the Code. There are no outstanding awards under the Director Plan. Approval of the Plan Amendment will constitute approval pursuant to the NASDAQ Stock Market
          shareholder approval requirements applicable to equity compensation plans and approval pursuant to the shareholder approval requirements of Section 422 of the Code relating to ISOs (to the extent required by the Code).</div>
      </div>
      <div style="color: #000000;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div><br>
      </div>
      <div>
        <div style="text-align: justify; color: #000000;">If our shareholders do not approve the Plan Amendment pursuant to this Proposal 4, the additional shares proposed by the Plan Amendment will not become available for issuance and the existing Plan
          (not as amended by the Plan Amendment) will continue in full force and effect, without giving effect to the Plan Amendment, and we may continue to grant equity-based awards under the Plan subject to shares remaining available for grant under the
          Plan.</div>
        <div><br>
        </div>
        <div style="text-align: justify; font-style: italic; font-weight: bold;"><font style="color: #000000;">Material Terms of the Amended Plan -- </font>Limitation on Awards and Shares Available.</div>
        <div><br>
        </div>
        <div style="text-align: justify;">As of June 1, 2024, there were 431,875 shares remaining available for grant under the existing Plan (assuming the payout of outstanding PSUs, performance-based stock options and performance-based restricted stock
          at &#8220;target&#8221; performance goals). As described above, if this Proposal 4 is approved, then, as of the Amendment Effective Date, the number of shares reserved for issuance under the Amended Plan will be equal to the sum of (1) 2,655,200 shares of
          our common stock, plus (ii) any shares which are subject to awards granted under the 2010 Plan (&#8220;Prior Plan Awards&#8221;) or under the Director Plan (&#8220;Prior Director Plan Awards&#8221;) that again become available for grant pursuant to the terms of the
          Amended Plan (the &#8220;Share Limit&#8221;). There are no outstanding Prior Director Plan Awards. The shares issued under the Amended Plan may be treasury shares, authorized but unissued shares, or shares purchased in the open market. The maximum number of
          shares that may be issued upon the exercise of ISOs is 2,655,200.</div>
        <div style="text-align: justify; color: #000000; font-weight: bold;"> <br>
        </div>
        <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">The Board of Directors recommends that shareholders vote FOR the approval of the First Amendment to the</div>
      </div>
      <div>
        <div style="text-align: center; color: #000000; font-weight: bold;">Motorcar Parts of America, Inc. 2022 Incentive Award Plan.</div>
      </div>
      <div style="color: #000000; font-weight: bold;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div><br>
      </div>
      <div style="text-align: center; color: #000000; font-weight: bold;"><u>Supplement Appendix A</u></div>
      <div><br>
      </div>
      <div style="text-align: center; color: #000000; font-weight: bold;">FIRST AMENDMENT TO</div>
      <div style="text-align: center; color: #000000; font-weight: bold;">MOTORCAR PARTS OF AMERICA, INC.</div>
      <div style="text-align: center; color: #000000; font-weight: bold;">2022 INCENTIVE AWARD PLAN</div>
      <div>
        <div><br>
        </div>
      </div>
      <div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: #000000;">This First Amendment (&#8220;<u>First Amendment</u>&#8221;) to the </font>Motorcar Parts of America, Inc. <font style="color: #000000;">2022 Incentive Award Plan (the &#8220;<u>Plan</u>&#8221;),
            is adopted by the Board of Directors (the &#8220;<u>Board</u>&#8221;) of </font>Motorcar Parts of America, Inc.<font style="color: #000000;">, a New York corporation (the &#8220;<u>Company</u>&#8221;), effective as of September 5, 2024 (the &#8220;<u>Amendment Effective
              Date</u>&#8221;). Capitalized terms used in this First Amendment and not otherwise defined herein shall have the meanings ascribed to such terms in the Plan.</font></div>
      </div>
      <div>
        <div><br>
        </div>
      </div>
      <div style="text-align: center; color: #000000; font-weight: bold;">RECITALS</div>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z82becf58f2ca45dc9520a84feaf88daf">

          <tr>
            <td style="width: 36pt; vertical-align: top; color: #000000;">A.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: #000000;">The Company currently maintains the Plan.</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8ccf51014f4c4ee0a8e2c91f0644becc">

          <tr>
            <td style="width: 36pt; vertical-align: top; color: #000000;">B.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: #000000;">Pursuant to Section 13.1 of the Plan, the Plan may be wholly or partially amended or otherwise modified, suspended or terminated at any time or from time to time by the Board or the Compensation Committee of the
                Board, subject to approval by the stockholders of the Company twelve (12) months before or after such action.</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zcf1c7b1999e6461caf538f725a46aa19">

          <tr>
            <td style="width: 36pt; vertical-align: top;">C.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The <font style="color: #000000;">Board believes it is in the best interests of the Company and its stockholders to amend the Plan to (i) increase the number of shares which may be issued pursuant to awards under the Plan, including the
                  number of shares which may be issued under the Plan upon the exercise of Incentive Stock Options (as defined in the Plan), (ii) extend the term of the Plan and (iii) extend the period under which Incentive Stock Options may be granted
                  under the Plan.</font></div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="text-align: center; color: #000000; font-weight: bold;">AMENDMENT</div>
      <div><br>
      </div>
      <div style="text-align: justify; margin-left: 36pt;">The Plan is hereby amended as follows, effective as of the Amendment <font style="color: #000000;">Effective Date:</font></div>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z6fb74f4fe67d47568aca076f1fa8ea40">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: #000000;">1.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div><u>Section</u><font style="color: #000000;"><u> 3.1(a)</u>. Section 3.1(a) of the Plan is hereby amended and restated in its entirety with the following:</font></div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="text-align: justify; margin-left: 36pt;"><font style="color: #000000;">&#8220;Subject to Sections 3.1(b) and 13.2 hereof, the aggregate number of Shares which may be issued pursuant to Awards under the Plan shall be equal to the sum of (i)
          2,655,200 Shares; and (ii) any Shares which are subject to Prior Plan Awards and Prior Director Plan Awards which become available for issuance under the Plan following the Effective Date pursuant to Section 3.1(b) (the &#8220;<u>Share Limit</u>&#8221;). In
          order that the applicable regulations under the Code relating to Incentive Stock Options be satisfied, the maximum number of Shares that may be issued under the Plan upon the exercise of Incentive Stock Options shall be 2,655,200 Shares. </font>As
        of the Effective Date, the Company will cease granting awards under the Prior Plan and the Director Plan; however, awards issued under the Prior Plan and the Director Plan and outstanding as of the Effective Date will remain subject to the terms of
        the applicable plan.<font style="color: #000000;">&#8221;</font></div>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7cb9b613560e460aa4f64fb265eea46e">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: #000000;">2.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div><u>Section</u><font style="color: #000000;"><u> 13.3</u>. Section 13.3 of the Plan is hereby deleted and replaced in its entirety with the following:</font></div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div><br>
      </div>
      <div style="margin-left: 36pt;">&#8220;<u>Effective Date and Term of Plan</u>. The Plan shall be effective as of the Effective Date. Unless sooner terminated as provided herein, the Plan shall terminate, and no Award may be granted pursuant to the Plan
        after September 5, 2034; provided, however, that no Incentive Stock Option may be granted pursuant to the Plan after July 25, 2034.&#8221;</div>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf21d157955b84de7ba5c3dcb9d6ff8b2">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: #000000;">3.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>This First Amendment shall be and, as of the Amendment Effective Date, is hereby incorporated in and forms a part of the Plan.</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc269b86df3084ef5a0852155b8c27dc8">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: #000000;">4.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Except<font style="color: #000000;"> as expressly provided herein, all terms and conditions of the Plan shall remain in full force and effect.</font></div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
      <div> <br>
      </div>
      <div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"> </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>logo1.jpg
<TEXT>
begin 644 logo1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" !: +$# 2(  A$! Q$!_\0
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MO^LW#W_0 OZ^9ZO^KV>?]!;_ !/Q(_XB7/VF?^>_@3_P0G_X[1_Q$N?M,_\
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MW@FWS)Q5ENTY15_D?.W_  L?Q#_T'M9_\#9?_BJ/^%C^(?\ H/:S_P"!LO\
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MZK6['RM+QFX%G)Q=9*W>G+O;3W3\U/\ A8_B'_H/:S_X&R__ !5'_"Q_$/\
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M !0CG.1Z_P#\%J_B#<?#C_@FW\1[JT8I<:E;0:3D<?)<W,44H_&)Y!7YT?\
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M]J7]FSP]^UU\$-:\ >*1=?V+KB1^:]M)Y<\+QR++&Z,00&5T4\@@]""#7/\
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..,= HHHKD.H**** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>sig1.jpg
<TEXT>
begin 644 sig1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" !+ ,T# 2(  A$! Q$!_\0
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M10 4444 %%%% !1110 4444 %%%(7 /44 +13?,7=C(SZ9IU !1110 4444
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M9'^&?[+W@ZXT#X>^!_#7A#2;T[KJ#3+".#[8V",S,!NE."1ER<#@8'%>BT4
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KA?A]HB>(VUA=)TU=5?&Z\%K'Y[8! R^-W0GOWK8HH :L05L\TZBB@#__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
